Excellent U-Vacuum thermal insulation material + rigid polyurethane foam! Improved heat retention and insulation effect.
We would like to introduce the biomedical freezer "VH Series" handled by Biomediqa Solutions Co., Ltd. It achieves a minimum temperature of -40°C. The exterior, interior, and door are made of painted steel plates, and the shelves are coated with polyethylene on hard steel wire. With excellent U-Vacua vacuum insulation material and rigid polyurethane foam due to VIP vacuum insulation technology, the thermal insulation and heat retention have been improved. 【Features】 ■ Low-temperature storage container ■ Minimum temperature of -40°C ■ Excellent U-Vacua vacuum insulation material ■ Rigid polyurethane foam used as insulation material ■ Improved heat retention and insulation effect *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【BMF-U340VH Specifications (Excerpt)】 ■External dimensions: W616×D770×H1,806mm ■Effective capacity: 369L ■Power supply: Single-phase AC100V, 50/60Hz ■Product weight: 138kg ■Exterior, interior, and door: Painted steel plate *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■Low-temperature storage container *For more details, please refer to the PDF document or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.